Home
overview

SMi Group are thrilled to present the launch of Injectable Drug Delivery Conference 2018! The event is taking place in central London on 16th and 17th May 2018, with two pre-conference workshops occurring on 15th May 2018.

The Global Injectable Drug Delivery Market is expected to reach $789.7 billion USD by 2024, with a compound annual growth rate (CAGR) of 11.5% during the period of 2017 to 2024, according to Research Markets Reports*. Therefore, this conference will aim to discuss the next generation of injectable drugs and devices through exploring emerging technologies and new market opportunities.

(*The report can be found at: https://www.marketsandmarkets.com/PressReleases/injectable-drug-delivery.asp.)

Topics that will be covered include:

  • Emerging technologies and opportunities
  • Developing the next generation of devices
  • Advancing the fill and finish process
  • Revolutionizing the patient experience
  • Developing better biologics
  • Design considerations

The Conference:

  • Evaluate solutions for high-volume and highly-viscous drug formulations and explore their increasing market opportunities
  • Revolutionise the patient experience through connected technologies, wearable injectors and maintenance of patient-centric design processes
  • Gain insight into the design strategies of industry-leaders
  • Discover the practical industrial solutions to tackling the critical fill and finish process
  • Learn how vial-based novel delivery technologies can overcome complex dosing regimens
  • Address present and future challenges in injectable peptide delivery
     

We Are One of A Kind...

Networking: We keep networking at the forefront when it comes to our attendees. Expand your community with every part of the industry and with the right people to benefit your company and develop your career.

The Agenda: Be sure to have your pen and pad ready at all times! A valuable time is spent to discover the latest trends and hottest topics in the industry to provide the best possible agenda for our attendees.

Location/Venue: Being held in the heart of London, The Holiday Inn Kensington Forum, London is an elegant contemporary four-star hotel in prestigious Kensington, located just a few minutes’ walk from High Street Kensington underground station, making exploring easy. See the wonderful sights of Kensington, by visiting Kensington Palace, the historical Museums, or take a stroll in Kyoto Garden!

Onsite: Our knowledgeable events team will provide you with an exceptional service onsite. They will answer any questions you may have and inform you about any changes to the agenda.

Alkermes Plc., Antares Pharma, Battelle, Baxter International, Becton, Bend Research, BioDelivery Sciences, Bristol-Myers Squibb, Dickinson and Company, Elcam Medical, Eli Lilly and Company, Enesi Pharma, F. Hoffmann-La Roche Ltd, Flextronics Medical, Formac Pharmaceuticals, Genetech Inc, Gerresheimer AG, GlaxoSmithKline, Haselmeier, Mati Therapeutics, Merck & Co Inc, Mylan N.V., Nova Laboratories Ltd, Novartis, Novo Nordisk, Oncolytics Biotech, Owen Mumford Ltd, Parenteral Drug Association, Pfizer, PolyActivaUnilife, Roche, Rovi Contract Manufacturing S.L., Salvus Technology Limited, Sandoz, Sanofi, Schott AG, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Toxikon, West Pharmaceutical Services Inc, Xellia Pharmaceuticals, Ypsomed Holding AG..

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Maxime Gaillot

Maxime Gaillot, Senior Device Engineer, F. Hoffmann-La Roche Ltd
View Bio

9:10 Vial Based Novel Delivery Technology

Maxime Gaillot

Maxime Gaillot, Senior Device Engineer, F. Hoffmann-La Roche Ltd
View Bio

• Weight based-dosing limits the primary packaging selection and impacts the number of potential different product presentations
• Discover how vial-based presentation can provide a solution to these complex dosing regiments
• Understand the background of vial-based presentation
• Learn the specifics of this novel delivery technology

9:50 Tips, tricks and common sense for a successful Human Factors Usability file

Serge Dubeau

Serge Dubeau, Vice President of Design and Human Factors , Worrell
View Bio

• Review what considerations make a usability file successful with Regulatory Bodies
• Discuss how to interpret the standards/guidance as regulation evolves
• Explore the Human Factors process through a wide range of devices’ Usability Engineering files

10:30 Morning Coffee

11:00 Enable Injections: A Drug Delivery Technology to Enable your Portfolio

Michael Hooven

Michael Hooven, President and CEO, Enable Injections
View Bio

• Technology – overview of the device technology and the benefits it provides to patients, companies, and overall healthcare
• Business Structure – a mix of pharma and device executives
• Manufacturing – overview of Clinical and Commercial Manufacturing, highlighting our partnership with Flex
• Partnering Process – discuss pipeline from feasibility to commercialization

11:40 Designing devices for a future portfolio

Andrew Fiorini

Andrew Fiorini, Investigator, Device Engineering, GSK
View Bio

• Defining parameters and requirements
• Engaging stakeholders. How? Who? And when?
• Designing with the end users

12:20 Networking Lunch

13:20 Risk Management activities for combination product (device part)

Francesco Malavasi

Francesco Malavasi, Quality Risk Manager Medical Devices, Novartis Pharma GmbH
View Bio

• Risk management: Why and What?
• Type of risk analysis
• Benefit during design control
• Case study of a PFS with NSD

14:00 Fill and finish of biotech products and hazards associated: Derisking approach

Mostafa Nakach

Mostafa Nakach, Head of Pharmaceutical Engineering Group, Sanofi-Aventis R&D
View Bio

 The presentation outlines the description of the scientific methodology that comports several steps:

  1.  Basic data acquisition focusing on the main physical chemistry properties of the drug product. This step is the foundation of the process development: all process development should be based on product knowledge
  2. Preliminary calculations of process parameters based on prior knowledge using simulation tools in order to anticipate process parameters of freezing, thawing, mixing, filtration and filling parameters. The values allow to have a first idea of the process design space and to restrict the experimental domain
  3. Set-up of Design space using Lab scale tests for each operation units in order to fine tune the calculation results. Thanks to preliminary calculations the number of experiments to be performed is reduced
  4. Set-up of robust and efficient scale-up that can lead to stable products in the monitored quality attributes

14:40 Afternoon Tea

15:10 What does it take to be patient centric?

Fie Falck Larsen

Fie Falck Larsen, Device Design Engineer, LEO Pharma A/S
View Bio

• Shaping usability to fit the organization
• Systemising user involvement with tools and templates
• Hands on experience with study design and implementation
• Involving key stakeholders in the process to secure anchoring of study insights

15:50 How connected are we to our users

Uri Baruch

Uri Baruch, Head of Drug Delivery, Cambridge Design Partnership
View Bio

• There is a consensus these days that better usability will lead to better adherence and uptake
• One of the challenges we face today is how to get early real usability data to give us design insights to improve devices
• A novel approach is to use existing connected technology to monitor users over a longer time period than a formative study and understand long-term use behaviour such as training decay, adherence and use errors associated with longer use
• Jobs to be done approach is used to understand which metrics should be measured
• We will show Data analytics from long term studies we have conducted, discuss how there were analysed and what insights were gained

16:30 Chairman’s Closing Remarks and Close of Day One

Maxime Gaillot

Maxime Gaillot, Senior Device Engineer, F. Hoffmann-La Roche Ltd
View Bio

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Joel Richard

Joel Richard, Senior Vice President, Peptides, IPSEN
View Bio

9:10 Injectable Peptide Delivery: How Can Nanosystems Help Address Present and Future Challenges

Joel Richard

Joel Richard, Senior Vice President, Peptides, IPSEN
View Bio

• Peptide therapeutic landscape
• Injectable peptide sustained-release (SR) formulations
• Peptide delivery to the brain
• Peptide delivery to tumors and cells
• Alternative non-invasive peptide delivery routes

9:50 PANEL DISCUSSION: Tackling high-volume and highly viscous drug formulations

• Describing current market opportunities and trends
• What common user problems do patients experience and how have you mitigated these issues?
• What design challenges have you faced and how have you overcome these hurdles?
• Identifying the best possible innovative drug delivery solution for your drug product
• What novel technologies are you developing to combat difficult formulations?
• Predicting the future of injectable biologics

Rene Holm

Rene Holm, Head & Scientific Director, Janssen
View Bio

Joel Richard

Joel Richard, Senior Vice President, Peptides, IPSEN
View Bio

Pierre Goldbach

Pierre Goldbach, Late Stage Pharmaceutical and Processing Development, Roche Pharmaceuticals
View Bio

Ahmed Youssef

Ahmed Youssef, Head of Parenteral Unit, GMP Manufacturing Group, Sanofi-Aventis
View Bio

James Blakemore

James Blakemore, Senior Consultant, Cambridge Consultants Ltd
View Bio

10:30 Morning Coffee

11:00 Drug product: The big picture

Ahmed Youssef

Ahmed Youssef, Head of Parenteral Unit, GMP Manufacturing Group, Sanofi-Aventis
View Bio

• Formulation development
• Drug product The big picture
• From Lab to Industry

11:40 Long Acting Injectables – current trends

Rene Holm

Rene Holm, Head & Scientific Director, Janssen
View Bio

  • A generalized overview of technical options for LAIs
  • Biopharmaceutical elements of LAI’s
  • Excipient and importance of excipient understanding for LAIs
  • A summary of exciting new data
  • 12:20 Networking Lunch

    13:20 Compatibility challenges of biologics with high volume injectors

    Pierre Goldbach

    Pierre Goldbach, Late Stage Pharmaceutical and Processing Development, Roche Pharmaceuticals
    View Bio

    • Delivery of high volume biologics subcutaneously
    • Different types of devices for high volume injection
    • Compatibility testing with high volume injectors
    • Potential impact on biologics product quality

    14:00 Solutions to the problem of poor drug solubility

    Jayne Lawrence

    Jayne Lawrence, Head of Division, Division of Pharmacy and Optometry, University of Manchester
    View Bio

    • techniques available used to increase apparent aqueous drug solubility
    • matching a drug with the most appropriate technique
    • clinical benefit and potential of technologies

    14:40 Afternoon Tea

    15:10 Product development of 9-THC injection: Development challenges of an oily drug substance

    Ee Li

    Ee Li, R&D Technical Specialist, Barts Health NHS Trust
    View Bio

    • Barts Health Pharmaceuticals and the limitation of the production
    • Requirements for THC injections
    • Initial challenges during product design
    • Unexpected adsorption issue and further investigation
    • Future development: Pre-filled syringes?

     

    15:50 Experience Design for Pharmaceutical Delivery Systems – Design Strategies and Learnings

    Cedric Gysel

    Cedric Gysel, Staff Device Engineer, Janssen
    View Bio

  • Usability vs. User Experience
  • Behavioural design
  • Internal and external drivers for experience design strategies
  • Human centered design and design controls
  • Insights and examples from Janssen

     

  • 16:30 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Ahmed Youssef

    Ahmed Youssef

    Head of Parenteral Unit, GMP Manufacturing Group, Sanofi-Aventis
    Andrew Fiorini

    Andrew Fiorini

    Investigator, Device Engineering, GSK
    Cedric Gysel

    Cedric Gysel

    Staff Device Engineer, Janssen
    Ee Li

    Ee Li

    R&D Technical Specialist, Barts Health NHS Trust
    Fie Falck Larsen

    Fie Falck Larsen

    Device Design Engineer, LEO Pharma A/S
    Francesco Malavasi

    Francesco Malavasi

    Quality Risk Manager Medical Devices, Novartis Pharma GmbH
    Jayne Lawrence

    Jayne Lawrence

    Head of Division, Division of Pharmacy and Optometry, University of Manchester
    Joel Richard

    Joel Richard

    Senior Vice President, Peptides, IPSEN
    Maxime Gaillot

    Maxime Gaillot

    Senior Device Engineer, F. Hoffmann-La Roche Ltd
    Michael Hooven

    Michael Hooven

    President and CEO, Enable Injections
    Mostafa Nakach

    Mostafa Nakach

    Head of Pharmaceutical Engineering Group, Sanofi-Aventis R&D
    Pierre Goldbach

    Pierre Goldbach

    Late Stage Pharmaceutical and Processing Development, Roche Pharmaceuticals
    Rene Holm

    Rene Holm

    Head & Scientific Director, Janssen
    Serge Dubeau

    Serge Dubeau

    Vice President of Design and Human Factors , Worrell
    Uri Baruch

    Uri Baruch

    Head of Drug Delivery, Cambridge Design Partnership

    Ahmed Youssef

    Head of Parenteral Unit, GMP Manufacturing Group, Sanofi-Aventis
    Ahmed Youssef

    He studied Pharmacy at the university of Tanta, Egypt where he also get his master degree in Pharmaceutical technology. He obtained his PhD in prediction of long term stability of protein formulations from the Ludwig Maximillian university in Munich Germany. He joined Sanofi in 2009 as a lab head for protein formulation development and since July 2015 he joined the GMP manufacturing group as head of parenteral unit for Clinical goods manufacturing. Ahmed has supervised the Drug product development of many projects in different phases mainly for Therapeutic proteins and antibodies. Starting from very early Phase formulation development going through formulation optimization, process development, 1ry packaging development and drug device combination ending with very late phase development, tech transfers and commercialization.

    Andrew Fiorini

    Investigator, Device Engineering, GSK
    Andrew Fiorini

    I have a B.Eng (Hons) in Mechanical Engineering from University of Malta and a MSc. in Biomedical Engineering from Imperial College London. I have been with GSK in Device Engineering for the past four years. I have worked on developing a number of different parenteral technologies, both in late stage commercialisation as well as early development. Currently I’m part of an Early stage parenterals team managing the development of device solutions for GSK future parenteral portfolio.
     

    Cedric Gysel

    Staff Device Engineer, Janssen
    Cedric Gysel

    Cedric is a device engineer and technical product owner at Janssen (Pharmaceutical Companies of J&J). He holds a master’s in medical device technology with a specialisation in human centered design from the University of Applied Science in Berne. After working for Novartis and Actelion in different research and development roles, he joined Janssen in 2005 where he has held different development and market support roles. He is also a guest lecturer at the Berne University of Applied Science and a member of the Human Centered Design Workgroup of Swiss Medtech.

    Ee Li

    R&D Technical Specialist, Barts Health NHS Trust
    Ee Li

    Currently working in Pharmacy Manufacturing Unit, Royal London Hospital, Barts Health NHS Trust.
    E Li gained her degree in Pharmaceutical Analysis Sciences/Formulation from Tianjin Medical University, China and she has a MSc degree in Physical Organic Chemistry from University of Durham
    She has over 15 years of work experience in hospital Pharmacy Manufacturing Units, GSK and a multi-disciplinary Contract Research Organisation in Cambridgeshire.
    She is a member of Royal Society of Chemistry and her research interest varies from research into the design, manufacturing and analysis of inhalation products and injectable products etc.
     

    Fie Falck Larsen

    Device Design Engineer, LEO Pharma A/S
    Fie Falck Larsen

    Fie Falck Larsen is a senior usability engineer at LEO Pharma with more than 10 years’ experience within development of medical devices and combination products and has a passion for human factors engineering and patient centricity. She holds a master´s degree in design engineering from Aalborg University in Denmark. Fie joined LEO Pharma in 2015 and plays a central role in making usability come to life in the device organization. Today she is responsible for the injection device usability activities.

    Fie Larsen

    Device Design Engineer, LEO Pharma A/S
    Fie Larsen

    Francesco Malavasi

    Quality Risk Manager Medical Devices, Novartis Pharma GmbH
    Francesco Malavasi

    Francesco brings along over 10 years of Medical Device industry experience and knowledge in several different business areas and a broad area of functions, including 4 years’ experience in “combination product” development. Currently is Medical Device Quality Risk manager at Novartis BTDM covering product and processes risk related activities for combination product (or borderline products) and medical Devices.
    He has an aeronautical background nevertheless is currently is pursuing a degree as Management Engineering.

    James Blakemore

    Senior Consultant, Cambridge Consultants Ltd
    James Blakemore

    James Blakemore is a Senior Consultant in the Medical Technology division at Cambridge Consultants. He specialises in market strategy and transaction support within the pharmaceutical and drug delivery device markets. He manages drug delivery device development projects bringing together commercial insight and technical expertise. Prior to working in the healthcare consulting industry, Dr Blakemore worked in a number of business development and licensing roles for speciality pharmaceutical and biotechnology companies, working towards the identification, validation and commercialisation of broad new therapies. He holds a PhD in Molecular Biology from King’s College, University of London, UK.

    Jayne Lawrence

    Head of Division, Division of Pharmacy and Optometry, University of Manchester
    Jayne Lawrence

    Jayne is currently Head of the Division of Pharmacy and Optometry at Manchester University, a position she took up in the summer of 2017. Prior to that Jayne was Professor and Head of the Pharmaceutical Biophysics Group in the Pharmacy Department at King’s College London. Until the spring of 2017 Jayne was on a half time secondment as the Chief Scientist at the Royal Pharmaceutical Society where she commented in the National media on a number of pharmaceutical science issues including antimicrobial resistance, biologicals and biosimilars and patient safety. Jayne is a pharmacist by training who, in addition to working in academia, has also spent time working in community, hospital and industrial pharmacy. Her research is focussed on improving the delivery of drugs and genes, with special interest in increasing drug solubility. In addition to presenting her work at national and international conferences, she on a number of national and international committees and grant awarding bodies.

    Joel Richard

    Senior Vice President, Peptides, IPSEN
    Joel Richard

    Dr Joël Richard is presently leading all the Pharmaceutical Development activities of Peptides & Small Molecules for the Ipsen Company. Dr Richard has got his PhD in Materials Science/Colloids & Interface Science from University of Paris VI. He has more than 25 years of experience in chemistry and biopharmaceutical R&D, including several global senior leadership positions in various Biotech and Pharma companies, such as Ipsen, Merck Serono, Serono and Ethypharm.
    Dr Richard has focused his research activity on new formulations and drug delivery systems (such as microspheres, nanoparticles,. . .), especially for injectable protein and peptide formulations. Dr Richard has published 68 peer-reviewed scientific papers, 8 book chapters and 2 editorials in various fields. He is the author of more than 120 international communications and 53 patent families.

    Maxime Gaillot

    Senior Device Engineer, F. Hoffmann-La Roche Ltd
    Maxime Gaillot

    Maxime Gaillot works for Roche since 2011. He has 15 years experience in the medical device and polymer industry. After some years, in the plastic closure industry, Maxime started his career in the Medical Device industry at Novartis. He worked on the development of a dual chamber pen injector and an electronic reusable injector. Since 2011 at Roche, he was a single mater expert for Needle Safety Device and supported the filing for a Rheumatoid Arthritis treatment and the development of the Roche Needle Safety Training Device. Currently, he is the Device Team Leader for several molecules and the ad interim Section Head for Device Engineering. In addition, Maxime is leading the development of a new vial based pen device to support clinical trial or challenges for weight based treatment. Maxime is graduated from the ENSAM Paris in Mechanical Engineering.

    Michael Hooven

    President and CEO, Enable Injections
    Michael Hooven

    Mike has over 30 years of experience in the medical device industry in a broad variety of technical and clinical areas. He is the founder of five medical device companies and holds over 100 issued and pending US patents. He earned a BS in Physics and a Master of Science in Mechanical Engineering from the University of Michigan.

    Mostafa Nakach

    Head of Pharmaceutical Engineering Group, Sanofi-Aventis R&D
    Mostafa Nakach

    Mostafa Nakach has a PhD from Toulouse University. He has prepared his thesis on stabilization and production of nanocrystalline suspension. He is also a Master 2 graduate from Paris-sud 11 university in Pharmacotechnie and Biopharmacy and Pharmaceutical Engineering from Ecole des Mines d’Albi. Mostafa has been working within Sanofi group for 30 years. His current position is a head of pharmaceutical engineering section within pharmaceutical science operations.
    His mission is to build and to manage the required skills and capabilities in order to support R&D projects development mainly for:

    1) Formulation design of nano-vectors
    2) Fill&finish Commercial process development of biotech products
    3) Development and adaptation to pharmaceutical regulation of new manufacturing processes (nanotechnologies, amorphization, spray drying, freeze drying etc….)
    4) identification of critical steps and relevant monitoring to manufacture a product exhibiting the expected quality attribute
    5) implementation of pharmaceutical engineering tool box that will contribute to the implementation of QBD approach
    6) modelling scale down and scale-up rules
    7) design and set-up/qualification/validation of equipments and pilots aimed at manufacturing nanotechnology-based product

    Mostafa Nakch worked also as API physical quality research engineer within chemical development department. His mission was focused on the process development of solid chain: from crystallization to particles engineering.
     

    Pierre Goldbach

    Late Stage Pharmaceutical and Processing Development, Roche Pharmaceuticals
    Pierre Goldbach

    Dr. Goldbach joined F. Hoffmann-La Roche Ltd (Basel, Switzerland) in 1994 as Lab Head in the department of Formulation R&D Parenteral Dosage Forms, with the main focus based on development and supplies of parenteral formulations for NCEs.
    In 2004, he moved to the department of Formulation R&D Biologics and started to work on formulation development and supplies for Biologics. Since 2010, Dr. Goldbach is Senior Group Leader in the department of Late-Stage Pharmaceutical and Processing Development with the main focus based on commercial formulation and process development for Biologics, including combination products.
    Dr. Goldbach holds a PhD in pharmaceutical technology from the University of Paris XI (Châtenay Malabry) and studied Pharmacy at the School of Pharmacy of Strasbourg (University Louis Pasteur).

    Rene Holm

    Head & Scientific Director, Janssen
    Rene Holm

    René Holm received his pharmaceutical training at the Royal Danish School of Pharmacy, now the school of pharmacy at University of Copenhagen, Denmark, in 1998 and his PhD in biopharmaceutics from the same institution in 2002. Dr. Holm joined Lundbeck in 2001 and changed to Janssen in 2016. Dr. Holm has worked within pharmaceutical development, formulations for non-clinical testing in drug discovery, physical chemistry and material science covering both small and large molecules and is now responsible for the functional unit ensuring development of all non-solid formulations for Janssens small molecule value stream.

    Dr. Holm is (co-) author of more than 150 original articles in peer-reviewed journals and patents in the field of biopharmaceutics, preformulation, formulation and physical pharmacy.

    Serge Dubeau

    Vice President of Design and Human Factors , Worrell
    Serge Dubeau

    In his nearly 20 years of experience, Serge has lead design and engineering teams in a variety of projects for both Fortune 100 and start up companies, resulting in various design awards and more than a dozen patents. He currently leads the design and human factors engineering teams at Worrell, focusing on user and patient safety. He holds a degree in Industrial Design from the University of Montreal, and is multi-lingual, having lived and worked in Spain, Canada and the United States.

    Uri Baruch

    Head of Drug Delivery, Cambridge Design Partnership
    Uri Baruch

    Uri heads up the drug delivery team at Cambridge Design Partnership, where he has led a variety of design projects including an award-winning needle safety device, an emergency auto-injector, pen injectors, and packaging design for delivery devices and inhalation products. These projects included compiling design history files and led to successful submissions to both the Food and Drug Administration and the European Medicines Agency in several submission categories.
    Uri has a master’s degree in engineering from the IIT, where he specialised in MEMS design and materials engineering. He has worked in a variety of industries including aerospace and defence, medical devices, automotive and inkjet. He has extensive knowledge of design for manufacturing and process design.
     

    Sponsors and Exhibitors

    Supporters

    Workshops

    Wearable Injectors : Serving Clinical and Healthcare System Needs
    Workshop

    Wearable Injectors : Serving Clinical and Healthcare System Needs

    Holiday Inn Kensington Forum
    15th May 2018
    London, United Kingdom

    VENUE

    Holiday Inn Kensington Forum

    97 Cromwell Road , London, United Kingdom

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    [DAY 1 | 16TH MAY 2018] - FULL PROGRAMME

    Download

    [SPEAKER INTERVIEW] - Fie Falck Larsen - LEO Pharma

    Download

    [SPEAKER INTERVIEW] - Cedric Gysel - Janssen

    Download

    [SPEAKER INTERVIEW] - Ahmed Youssef - Sanofi-Aventis

    Download

    [SPEAKER INTERVIEW] - Joel Richard - Ipsen

    Download

    [SPEAKER INTERVIEW] - Maxime Gaillot - Roche

    Download

    [LIVE SPONSOR SPEAKER INTERVIEW] - WORRELL

    Download

    [FULL ATTENDEE LIST] - 2018 CONFIRMED ATTENDEES

    Download

    [WORKSHOP B] - FULL DETAILS, OVERVIEW & BIO

    Download

    [WORKSHOP A] - FULL DETAILS, OVERVIEW & BIO

    Download

    [2018 BROCHURE] - IDD

    Download

    [DAY 2 | 17TH MAY 2018] - FULL PROGRAMME

    Download

    [LIST OF 2018 SPEAKERS] - This Year's Line-up

    Download

    [ATTENDEE LIST] - PRE-FILLED SYRINGES EUROPE 2018

    Download

    Sponsors and Exhibitors


    Crux Product Design Ltd

    Sponsors and Exhibitors
    http://www.cruxproductdesign.com

    Crux is a medical focused device development agency. Our passion is to develop, innovative, award-winning, class-leading products. We collaborate strategically with client teams to develop beautiful, intelligent products that perform in the real world. We provide high-end and fully integrated design, engineering, software & electronics with App creation & integration. Our agility and effectiveness at generating creative design concepts and being able to rapidly prove out design principles is making us the go-to technically adept design partner. The Crux team consists of industry experts with diverse and highly specialist capabilities closely supporting every step of your product development journey.


    Worrell

    Sponsors and Exhibitors
    http://www.worrell.com

    Worrell is a multifaceted healthcare design and innovation firm with offices in London, Minneapolis and Shanghai. Worrell provides expertise in research and strategy, user experience and industrial design, human factors engineering and prototyping. Working on the front lines with patients and healthcare professionals, Worrell uncovers unmet needs to bring new drug delivery, medical device, and digital health solutions to the market.

    Media Partners


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


    Drug Target Review

    Supporters
    http://www.drugtargetreview.com

    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


    SciDoc Publishers

    Supporters
    http://www.scidoc.org

    SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals - Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications - online.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    ONdrugDelivery Magazine

    Supporters
    http://ondrugdelivery.com

    ONdrugDelivery Magazine is the highly regarded, world-leading series of sponsored themed drug delivery publications. Uniquely, each issue focuses tightly on one topic within the field of drug delivery. With a truly global readership already in excess of 40,000, and with contributions and loyal support from many of the most important companies in the drug delivery business - from among the largest to the smallest - ONdrugDelivery Magazine is a must for those in the industry who need to know what's going on in drug delivery.


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Drug Development & Delivery

    Supporters
    http://www.drug-dev.com

    Drug Development & Delivery is a print/online content provider that presents the latest scientific methods in drug development for professionals.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out